Saturday, May 15, 2021

Tag: Covaxin phase 3 trial

Explained: What phase 3 data says on Bharat Biotech’s Covaxin vaccine

0
Covaxin, the vaccine manufactured by Bharat Biotech, has demonstrated overall interim clinical efficacy of 78 per cent, and 100 per cent efficacy against severe...

Coronavirus | Very few post-vaccine infections, says ICMR

0
ICMR says such ‘breakthrough’ cases do not undermine the efficacy of shots. Officials said that a “small” fraction of those vaccinated with either Covaxin...

Coronavirus | With more than 3 lakh cases, India records world’s...

0
The country reported as many 3,15,660 cases and 2,091 deaths. For the first time, more than 3 lakh COVID-19 cases were registered in a single...